Aurobindo Pharma to Buy Solar Power From Open Access Projects in Telangana

The company will invest ₹107.6 million to acquire 26% capital shares in two open access power projects

February 24, 2021

Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights

Aurobindo Pharma, a Hyderabad-based pharmaceutical company, will procure solar power from two 15 MW group captive projects of NVNR Power and Infra in Hyderabad, Telangana.

Continue Reading with Premium Access

Get unlimited access to in-depth analysis, exclusive interviews, and comprehensive coverage of India's renewable energy sector.

✓Unlimited article access

✓Exclusive market insights

✓Premium research reports

✓Ad-free reading experience

Loading subscription plans...

Already a subscriber? Sign In

Harsh Shukla

Comments

Get the most relevant India solar and clean energy news.

Aurobindo Pharma to Buy Solar Power From Open Access Projects in Telangana

Continue Reading with Premium Access

Comments

Get the most relevant India solar and clean energy news.

RECENT POSTS